celiac disease
Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease.
Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an <span class="gene" id="23269601-0-66-71">IL-15</span> transgenic mouse model that recapitulates pathologic manifestations of <span class="disease" id="23269601-0-143-157">celiac disease</span>.